Advertisement

Rosacea Fulminans

  • Cristina Caridi
  • Joshua A. Zeichner
Chapter

Abstract

Rosacea fulminans is a rare dermatosis characterized by the sudden onset of coalescing nodules and draining sinuses on the face, typically affecting young women. First reported in 1940 by the name pyoderma faciale, it was thought to be an infiltrative pyoderma, possibly caused by tuberculosis, despite being unable to identify a cause [1]. It was not until 1992 that it was suggested that the condition was a form of rosacea, as all patients also experienced flushing and blushing along with the rapid and volatile onset. The term rosacea fulminans was then proposed [2]. Despite research, a bacterial infection has not been shown to play a pathogenic role, further evidence that the condition is not a pyoderma, but rather a severe variant of rosacea [3]. Rosacea fulminans has also been referred to as granulomatous rosacea.

Keywords

Benzoyl Peroxide Ocular Involvement Positive Rheumatoid Factor Increase Erythrocyte Sedimentation Rate Oral Isotretinoin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    O’Leary PA, Kierland RR. Pyoderma faciale. Arch Dermatol. 1940;41:451–62.CrossRefGoogle Scholar
  2. 2.
    Plewig G, Jansen T, Kligman AM. Pyoderma faciale a review and report of 20 additional cases: is it rosacea? Arch Dermatol. 1992;128:1611–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Sudy E, Urbina F. Pyoderma faciale: gram-negative recovery by means of needle aspiration. Cont Med Educ. 2002;69:261–4.Google Scholar
  4. 4.
    Ferahbas A, Utas S, Mistik S, Uksal U, Peker D. Rosacea fulminans in pregnancy case report and review of the literature. Am J Clin Dermatol. 2006;7(2):141–4.PubMedCrossRefGoogle Scholar
  5. 5.
    Massa MC, Su WP. Pyoderma faciale: a clinical study of twenty-nine patients. J Am Acad Dermatol. 1982;6:84–91.PubMedCrossRefGoogle Scholar
  6. 6.
    Dessoukey MW. Pyoderma faciale: manifestation of inflammatory bowel disease. Int J Dermatol. 1996;35:724–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Manna V, Marks R, Holt P. Involvement of immune mechanisms in the pathogenesis of rosacea. Br J Dermatol. 1982;107:203–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Rebora A, Drago F, Parodi A. May helicobacter pylori be important for dermatologists? Dermatology. 1995;191:6–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Szlachcic A, Sliwowski Z, Karczewska E, Bielana W, Pytko-Poloncyzk J, Konturek SJ. Helicobacter pylori and its eradication in rosacea. J Physiol Pharmacol. 1999;50:777–86.PubMedGoogle Scholar
  10. 10.
    Ormond P, Rogers S. Case 3: pyoderma faciale (PF) (rosacea fulminans). Clin Exp Dermatol. 2003;28:107–8.PubMedCrossRefGoogle Scholar
  11. 11.
    de Morais e Silva FA, Bonassi M, Steiner D, Ribeiro da Cunha TV. Rosacea fulminans in pregnancy with ocular perforation. J Ger Soc Dermatol. 2011;9:542–3.Google Scholar
  12. 12.
    Akhyani M, Daneshpazhooh M, Ghandi N. The association of pyoderma faciale and erythema nodosum. Clin Exp Dermatol. 2007;32:275–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Fender AB, Ignatovitch Y, Mercurio MG. Pyoderma faciale. Cutis. 2008;81:488–90.PubMedGoogle Scholar
  14. 14.
    Firooz A, Firoozabadi MR, Dowlati Y. Rosacea fulminans (pyoderma faciale): successful treatment of a 3-year-old girl with oral isotretinoin. Int J Dermatol. 2001;40:203–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Fuentalsaz V, Ara M, Corredera C, et al. Rosacea fulminans in pregnancy: successful treatment with azithromycin. Clin Exp Dermatol. 2011;36(6):674–6.CrossRefGoogle Scholar
  16. 16.
    Helm TA, Schechter J. Biopsy may help identify early pyoderma faciale (rosacea fulminans). Cutis. 2006;77:225–7.PubMedGoogle Scholar
  17. 17.
    Lewis VJ, Holme SA, Wright A, Antsey AV. Rosacea fulminans in pregnancy. Br J Dermatol. 2004;151:917–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Marks VJ, Briggaman RA. Pyoderma faciale: successful treatment with isotretinoin. J Am Acad Dermatol. 1987;17:1062–3.PubMedCrossRefGoogle Scholar
  19. 19.
    Ortonne JP. Oral isotretinoin treatment policy: do we all agree? Dermatology. 1997;195 Suppl 1:34–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Bormann G, Gaber G, Fischer M, Marsch WC. Dapsone in rosacea fulminans. J Eur Acad Dermatol Venereol. 2001;15(5):465–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Cristina Caridi
    • 1
  • Joshua A. Zeichner
    • 1
  1. 1.Department of DermatologyMt. Sinai School of MedicineNew YorkUSA

Personalised recommendations